Risperidone augmentation in treatment-resistant obsessive–compulsive disorder: a double-blind, placebo-controlled study

This double-blind, placebo-controlled trial was performed to determine the efficacy and tolerability of 8 wk of risperidone augmentation of serotonin reuptake inhibitor (SRI) treatment in adult subjects with treatment-resistant obsessive–compulsive disorder (OCD) (failure of at least two SRI trials)...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The international journal of neuropsychopharmacology 2003-12, Vol.6 (4), p.397-401, Article S1461145703003730
Hauptverfasser:	Hollander, Eric, Rossi, Nicolò Baldini, Sood, Erica, Pallanti, Stefano
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Ambulatory Care Antipsychotic Agents - administration & dosage Antipsychotic Agents - adverse effects Brief Reports Dose-Response Relationship, Drug Double-Blind Method Drug Administration Schedule Drug Resistance Drug Therapy, Combination Female Humans Male Middle Aged Obsessive compulsive disorder Obsessive-Compulsive Disorder - diagnosis Obsessive-Compulsive Disorder - drug therapy Obsessive-Compulsive Disorder - psychology Personality Inventory Risperidone - administration & dosage Risperidone - adverse effects Serotonin Uptake Inhibitors - adverse effects Serotonin Uptake Inhibitors - therapeutic use Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!